Claudia Wild

9PUBLICATIONS
5CO-AUTHORS
Investment and risk managementPharmaceutical delivery technologiesNatural products and bioactive compoundsBuilding science, technologies and systemsPlanning and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 01, 2026
Ownership changes in the pharmaceutical industry: understanding the 2023 pharma mergers and acquisitions landscape of Europe.

|Apr 01, 2026
Public contributions to the development of antibiotics: two successful and two failed investments.

Louise Schmidt, Ozren Sehic, Ursula Theuretzbacher

|Aug 07, 2025
The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.

Daniel Fabian, Ozren Sehic, Claudia Wild

|Feb 05, 2025
Implementation of the EU's Health Technology Assessment regulation: where does existing methods guidance require concretization and what are the relevant methodological options?

Gregor Goetz, Stefan Schandelmaier, Reinhard Busse

|Jan 23, 2025
'Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus'.

Louise Schmidt, Ozren Sehic, Ursula Theuretzbacher

|Nov 05, 2024
The role of health economics within health technology assessment: past, present, and future - an Austrian perspective.

Ingrid Zechmeister-Koss, Gregor Götz, Daniel Fabian

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Fabian

2 joint publications

Gregor Götz

1 joint publications

Iñaki Imaz-Iglesia

1 joint publications

Sari Susanna Ormstad